Literature DB >> 31669328

Vaginal dysbiotic bacteria act as pathobionts of the protozoal pathogen Trichomonas vaginalis.

Annabel S Hinderfeld1, Augusto Simoes-Barbosa2.   

Abstract

Trichomoniasis, a prevalent sexually transmitted infection caused by the protozoan parasite Trichomonas vaginalis, is often accompanied by a vaginal dysbiotic microbiota of pathogenic potential. Our objective was to investigate whether these dysbiotic bacteria act as pathobionts of T. vaginalis infection by altering pathogenic capabilities of the parasite, particularly in regard to adhesion to vaginal substrates and viability of human ectocervical cells. Assays interrogated the performance of T. vaginalis adhesion to biofilm produced by vaginal dysbiotic bacteria and whether these bacteria were capable of altering the ability of the parasite to bind to mucins and cells. The binding activities of T. vaginalis were quantified by flow cytometry. Host cell viability and apoptosis, as affected by T. vaginalis with or without the bacteria, were also measured experimentally. An in vitro biofilm was shown to provide adhesion for T. vaginalis. The binding of parasites to mucins and cells was modulated by the vaginal dysbiotic bacteria. Parasite cytoadhesion was significantly increased by these bacteria. In addition, these bacteria enhanced the pathogenic effects of the parasite to host cells. Together, this study showed that dysbiotic bacteria accompanying T. vaginalis infection in the vagina function as pathobionts as they are capable of enhancing the pathogenic capabilities of this parasite. This study highlights the importance of understanding the contribution of the vaginal microbiome to trichomoniasis.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adhesion; Bacterial vaginosis; Biofilm; Gardnerella vaginalis; Trichomonas vaginalis; Trichomoniasis; Vaginal microbiota

Mesh:

Year:  2019        PMID: 31669328     DOI: 10.1016/j.micpath.2019.103820

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  8 in total

1.  The interaction of gut microbiota with parasitic protozoa.

Authors:  Ozlem Ulusan Bagci; Ayse Caner
Journal:  J Parasit Dis       Date:  2021-08-27

2.  Feed Composition and Isolate of Histomonas meleagridis Alter Horizontal Transmission of Histomonosis in Turkeys. Proof of Concept.

Authors:  Thaina L Barros; Christine N Vuong; Juan D Latorre; Roberto S Cuesta; Elizabeth McGill; Samuel J Rochell; Guillermo Tellez-Isaias; Billy M Hargis
Journal:  Front Vet Sci       Date:  2022-06-28

3.  Two Different Species of Mycoplasma Endosymbionts Can Influence Trichomonas vaginalis Pathophysiology.

Authors:  Valentina Margarita; Nicholas P Bailey; Paola Rappelli; Nicia Diaz; Daniele Dessì; Jennifer M Fettweis; Robert P Hirt; Pier Luigi Fiori
Journal:  mBio       Date:  2022-05-24       Impact factor: 7.786

Review 4.  Impact of Symbiosis Between Trichomonas vaginalis and Mycoplasma hominis on Vaginal Dysbiosis: A Mini Review.

Authors:  Valentina Margarita; Pier Luigi Fiori; Paola Rappelli
Journal:  Front Cell Infect Microbiol       Date:  2020-05-08       Impact factor: 5.293

5.  Dysbiosis of fecal microbiota in cats with naturally occurring and experimentally induced Tritrichomonas foetus infection.

Authors:  Metzere Bierlein; Barry A Hedgespeth; M Andrea Azcarate-Peril; Stephen H Stauffer; Jody L Gookin
Journal:  PLoS One       Date:  2021-02-19       Impact factor: 3.240

Review 6.  Recent advances in the molecular biology of the protist parasite Trichomonas vaginalis.

Authors:  David Leitsch
Journal:  Fac Rev       Date:  2021-03-04

7.  Trichomonas vaginalis follow-up and persistence in Colombian women.

Authors:  Lauren Hernández-Buelvas; Milena Camargo; Ricardo Sánchez; Manuel Elkin Patarroyo; Manuel Alfonso Patarroyo
Journal:  Sci Rep       Date:  2021-11-19       Impact factor: 4.379

8.  Berberine Inhibits the Adhesion of Candida albicans to Vaginal Epithelial Cells.

Authors:  Ting Zhao; Kang Zhang; Gaoxiang Shi; Kelong Ma; Benfan Wang; Jing Shao; Tianming Wang; Changzhong Wang
Journal:  Front Pharmacol       Date:  2022-02-28       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.